AbbySVan VoorheesMD

PubMed

• 3 citations
  Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity.
  Clinton W Enos, Vanessa L Ramos, Robert R McLean, Tin-Chi Lin, Nicole Foster, Blessing Dube, Abby S Van Voorhees> ;The Journal of Dermatological Treatment. 2022 Nov 1
• Similar response to biologic therapy across racial and ethnic groups among patients with psoriasis enrolled in the CorEvitas Psoriasis Registry.
  Clinton W Enos, Julie Z Yi, Robert R McLean, Adam P Sima, Elizabeth A Kohl, Thomas Eckmann, Abby S Van Voorhees> ;Journal of the American Academy of Dermatology. 2022 Nov 1
• Cardiac and Sudomotor Autonomic Function in Subjects with Psoriasis With and Without Metabolic Syndrome.
  Carolina M Casellini, Henri K Parson, Michael D Bailey, Taylor Dyson, Abby S Van Voorhees, Aaron I Vinik, Elias S Siraj> ;Metabolic Syndrome and Related Disorders. 2022 May 1
• Inpatient Dermatology Consultations for Suspected Skin Cancer: A Retrospective Review.
  Scott M Whitlock, Arjun Saini, Katie A O'Connell, Thomas Michael Pender, Abby S Van Voorhees> ;Cutis. 2022 Mar 1
• 3 citations
  Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas' Psoriasis Registry.
  Jessica A. Walsh, Kristina Callis Duffin, Abby S. Van Voorhees, Soumya D. Chakravarty, Timothy Fitzgerald, Amanda Teeple, Katelyn Rowland, Jonathan Uy, Robert R. McLea...> ;Dermatology and Therapy. 2021 Nov 25
• 28 citations
  Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
  Alan Menter, Abby S. Van Voorhees, Sylvia Hsu> ;Dermatology and Therapy. 2021 Oct 9
• Response to: Successful implementation of phototherapy guidelines during the COVID-19 pandemic"."
  Henry W. Lim, Steve Feldman, Abby S. Van Voorhees, Joel M. Gelfand> ;Journal of the American Academy of Dermatology. 2021 Aug 14
• 12 citations
  Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: A prospective analysis in Corrona Psoria...
  Clinton W. Enos, Vanessa L. Ramos, Robert R. McLean, Tin-Chi Lin, Nicole Foster, Blessing Dube, Abby S. Van Voorhees> ;Journal of the American Academy of Dermatology. 2021 Jul 10
• 4 citations
  Psoriasis Severity, Comorbidities, and Treatment Response Differ among Geographic Regions in the United States
  Clinton W. Enos, Katie A O'Connell, Ryan W. Harrison, Robert R. McLean, Blessing Dube, Abby S. Van Voorhees> ;JID Innovations. 2021 Jun 1
• 3 citations
  Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study.
  A.S. Van Voorhees, L. Stein Gold, Mark Lebwohl, Bruce Strober, Howard Sofen, Kim Papp, Jerry Bagel, Z. Zhang, Maria Paris, Y. Wang> ;The British Journal of Dermatology. 2021 Mar 24
• 22 citations
  Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: The Corrona Psoriasis Registry.
  Benjamin Lockshin, Angel Cronin, Ryan W. Harrison, Robert R. McLean, Laura Anatale-Tardiff, Russel Burge, Baojin Zhu, William N Malatestinic, Bilal Atiya, Mwangi J Mur...> ;Dermatologic Therapy. 2021 Feb 15
• 68 citations
  National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Managemen...
  Joel M. Gelfand, April Armstrong, Stacie Bell, George L. Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D. Dommasch, Steven R. Feldman, Dafna D. Gladman, Leon H Ki...> ;Journal of the American Academy of Dermatology. 2021 Jan 7
• 34 citations
  National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
  Joel M. Gelfand, April Armstrong, Stacie Bell, George L. Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D. Dommasch, Steve R. Feldman, Dafna D. Gladman, Leon H Kir...> ;Journal of the American Academy of Dermatology. 2020 Dec 1
• 3 citations
  Geographic Variations in Biologic Therapy and Disease Characteristics: A Pilot-Study in the Corrona Psoriasis Registry
  Clinton W. Enos, Katie A O'Connell, Ryan W. Harrison, Robert R. McLean, Blessing Dude, Abby S. Van Voorhees> ;Journal of Drugs in Dermatology. 2020 Nov 1
• 2 citations
  Certolizumab for the treatment of localized pyoderma gangrenosum associated with Crohn's disease: A case report.
  Thomas Michael Pender, Grace Ayandibu, Abby S. Van Voorhees> ;Dermatologic Therapy. 2020 Oct 5
• 35 citations
  Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled...
  Abby S. Van Voorhees, Linda Stein Gold, Mark Lebwohl, Bruce Strober, Charles Lynde, Stephen K. Tyring, Ashley Cauthen, Howard Sofen, Zuoshun Zhang, Maria Paris, Yao Wang> ;Journal of the American Academy of Dermatology. 2020 Jul 1
• 7 citations
  Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics.
  Alan Menter, April W. Armstrong, Abby S. Van Voorhees, Clive Liu, Abby Jacobson> ;Dermatology and Therapy. 2020 Jun 12
• 5 citations
  Physical activity engagement and responses to exercise in plaque psoriasis: a multifactorial investigation of influential factors.
  Clinton W. Enos, Khaled Algrni, Abby S. Van Voorhees, Patrick B. Wilson> ;The Journal of Dermatological Treatment. 2020 Jun 10
• 23 citations
  Recommendations for phototherapy during the COVID-19 pandemic.
  Henry W. Lim, Steven R. Feldman, Abby S. Van Voorhees, Joel M. Gelfand> ;Journal of the American Academy of Dermatology. 2020 Jul 1
• 1 citations
  Recapture Rate of Brodalumab in Patients With a Lapse in Treatment.
  Mark Lebwohl, Jennifer Clay Cather, April W. Armstrong, Abby S. Van Voorhees, Abby Jacobson> ;Journal of Drugs in Dermatology. 2020 Apr 1
• Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry
  Abby S. Van Voorhees, Marc A Mason, Leslie R. Harrold, Ning Guo, Adriana Guana, Haijun Tian, Vivian Herrera, Bruce Strober> ;The Journal of Dermatological Treatment. 2021 Nov 17
• What will keep women practicing dermatology
  Abby S. Van Voorhees> ;International Journal of Women's Dermatology. 2020 Jan 1
• 7 citations
  Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona ...
  Abby S. Van Voorhees, Marc A Mason, Leslie R. Harrold, Ning Guo, Adriana Guana, Haijun Tian, Vivian Herrera, Bruce Strober> ;The Journal of Dermatological Treatment. 2021 Apr 3
• 7 citations
  Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study.
  Megan H. Noe, Marilyn T. Wan, Daniel B. Shin, April W. Armstrong, Kristina Callis Duffin, Zelma C. Chiesa Fuxench, Robert E. Kalb, Alan Menter, Eric L. Simpson, Junko ...> ;Journal of the American Academy of Dermatology. 2019 Oct 1
• 2 citations
  Achievement of the National Psoriasis Foundation treatment targets with ixekizumab: Pooled analyses from 4 clinical studies.
  April W. Armstrong, David Amato, William J. Huster, Clement K. Ojeh, Abby S. Van Voorhees> ;Journal of the American Academy of Dermatology. 2021 Aug 1
• Join now to see all

Lectures

• So Many Biologics, So Little Time: How to Pick Your Poison in an Era of Biologic Overload 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019